These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
495 related articles for article (PubMed ID: 8528099)
41. Regression of established breast carcinoma xenografts with antibody-directed enzyme prodrug therapy against c-erbB2 p185. Eccles SA; Court WJ; Box GA; Dean CJ; Melton RG; Springer CJ Cancer Res; 1994 Oct; 54(19):5171-7. PubMed ID: 7923136 [TBL] [Abstract][Full Text] [Related]
42. Targeted, gene-directed enzyme prodrug therapies to tackle diversity and aggression of late stage prostate cancer. Khatri A; Russell PJ Discov Med; 2007 Feb; 7(37):39-45. PubMed ID: 17343804 [TBL] [Abstract][Full Text] [Related]
43. Imaging beyond the diagnosis: image-guided enzyme/prodrug cancer therapy. Tong X; Chen X; Li C Acta Biochim Biophys Sin (Shanghai); 2011 Jan; 43(1):4-12. PubMed ID: 21134886 [TBL] [Abstract][Full Text] [Related]
44. The first generation of β-galactosidase-responsive prodrugs designed for the selective treatment of solid tumors in prodrug monotherapy. Legigan T; Clarhaut J; Tranoy-Opalinski I; Monvoisin A; Renoux B; Thomas M; Le Pape A; Lerondel S; Papot S Angew Chem Int Ed Engl; 2012 Nov; 51(46):11606-10. PubMed ID: 22996951 [TBL] [Abstract][Full Text] [Related]
45. Prodrugs for targeted tumor therapies: recent developments in ADEPT, GDEPT and PMT. Tietze LF; Schmuck K Curr Pharm Des; 2011; 17(32):3527-47. PubMed ID: 22074425 [TBL] [Abstract][Full Text] [Related]
46. Antibody-directed enzyme prodrug therapy. Connors TA Cancer Cells; 1990 Feb; 2(2):56-7. PubMed ID: 2397145 [No Abstract] [Full Text] [Related]
47. Targeted enzyme prodrug therapies. Schellmann N; Deckert PM; Bachran D; Fuchs H; Bachran C Mini Rev Med Chem; 2010 Sep; 10(10):887-904. PubMed ID: 20560876 [TBL] [Abstract][Full Text] [Related]
48. Comparison of activation of CPT-11 by rabbit and human carboxylesterases for use in enzyme/prodrug therapy. Danks MK; Morton CL; Krull EJ; Cheshire PJ; Richmond LB; Naeve CW; Pawlik CA; Houghton PJ; Potter PM Clin Cancer Res; 1999 Apr; 5(4):917-24. PubMed ID: 10213229 [TBL] [Abstract][Full Text] [Related]
49. Targeted prodrug approaches for hormone refractory prostate cancer. Aloysius H; Hu L Med Res Rev; 2015 May; 35(3):554-85. PubMed ID: 25529338 [TBL] [Abstract][Full Text] [Related]
50. Specific activation of glucuronide prodrugs by antibody-targeted enzyme conjugates for cancer therapy. Wang SM; Chern JW; Yeh MY; Ng JC; Tung E; Roffler SR Cancer Res; 1992 Aug; 52(16):4484-91. PubMed ID: 1643640 [TBL] [Abstract][Full Text] [Related]
51. Methotrexate-alpha-phenylalanine: optimization of methotrexate prodrug for activation by carboxypeptidase A-monoclonal antibody conjugate. Vitols KS; Haag-Zeino B; Baer T; Montejano YD; Huennekens FM Cancer Res; 1995 Feb; 55(3):478-81. PubMed ID: 7834611 [TBL] [Abstract][Full Text] [Related]
52. Clinical potential of gene-directed enzyme prodrug therapy to improve radiation therapy in prostate cancer patients. Vajda A; Marignol L; Foley R; Lynch TH; Lawler M; Hollywood D Cancer Treat Rev; 2011 Dec; 37(8):643-54. PubMed ID: 21481534 [TBL] [Abstract][Full Text] [Related]
54. Synthesis and biological evaluation of prodrugs based on the natural antibiotic duocarmycin for use in ADEPT and PMT. Tietze LF; Schmuck K; Schuster HJ; Müller M; Schuberth I Chemistry; 2011 Feb; 17(6):1922-9. PubMed ID: 21274943 [TBL] [Abstract][Full Text] [Related]
55. A novel antitumor prodrug platform designed to be cleaved by the endoprotease legumain. Stern L; Perry R; Ofek P; Many A; Shabat D; Satchi-Fainaro R Bioconjug Chem; 2009 Mar; 20(3):500-10. PubMed ID: 19196156 [TBL] [Abstract][Full Text] [Related]
56. Selective activation of anthracycline prodrugs for use in conjunction with ADEPT. HariKrishna D; Rao AR; Krishna DR Drug News Perspect; 2003 Jun; 16(5):309-18. PubMed ID: 12942162 [TBL] [Abstract][Full Text] [Related]
57. Tumor targeting: activation of prodrugs by enzyme-monoclonal antibody conjugates. Huennekens FM Trends Biotechnol; 1994 Jun; 12(6):234-9. PubMed ID: 7765070 [TBL] [Abstract][Full Text] [Related]
58. Antibody directed enzyme prodrug therapy (ADEPT) and related approaches for anticancer therapy. Jung M Mini Rev Med Chem; 2001 Nov; 1(4):399-407. PubMed ID: 12369965 [TBL] [Abstract][Full Text] [Related]
59. Gene-directed enzyme prodrug therapy for cancer: a glimpse into the future? Both GW Discov Med; 2009 Oct; 8(42):97-103. PubMed ID: 19833053 [TBL] [Abstract][Full Text] [Related]